SUMICHEM — Sumitomo Chemical India Balance Sheet
0.000.00%
- IN₹228.08bn
- IN₹211.98bn
- IN₹31.49bn
Annual balance sheet for Sumitomo Chemical India, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
R2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 5,317 | 5,604 | 5,635 | 8,911 | 12,594 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 9,670 | 9,598 | 10,605 | 10,039 | 10,010 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 23,044 | 25,220 | 27,879 | 26,729 | 30,203 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 3,130 | 4,071 | 4,795 | 4,982 | 4,986 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 26,719 | 30,096 | 33,691 | 33,133 | 39,644 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 10,810 | 10,214 | 9,334 | 8,007 | 9,652 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 11,307 | 10,824 | 9,873 | 8,717 | 10,633 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 15,412 | 19,272 | 23,818 | 24,416 | 29,011 |
| Total Liabilities & Shareholders' Equity | 26,719 | 30,096 | 33,691 | 33,133 | 39,644 |
| Total Common Shares Outstanding |